TABLE 2.
The biological functions and molecular mechanisms of miR-30d-5p.
Cancer type | Property | Functions | Genes/proteins/pathways | Refs |
---|---|---|---|---|
Lung cancer | Suppressor | Cell proliferation and motility inhibitor | Targeting CCNE2 | Chen et al. (2015) |
Suppressor | Cell proliferation, migration, and invasion inhibitor | Targeted by POU3F3 | Zeng et al. (2020) | |
Suppressor | Cell proliferation, migration, and invasion inhibitor | Targeting DBF4 | Qi et al. (2021) | |
Suppressor | Cell proliferation, invasion and stemness inhibitor | circCD151/miR-30d-5p/GLI2 axis | Zhao et al. (2021) | |
Suppressor | Malignant progression inhibitor and immune escape | LncRNA SOX2OT/miR-30d-5p/PDK1 driving PD-L1 through the mTOR signaling pathway | Chen et al. (2021) | |
Gallbladder carcinoma | Suppressor | Cell apoptosis promoter, and migration inhibitor | Targeting LDHA | He et al. (2018) |
Rectal cancer | Suppressor | Organ-specificity of metastasis inhibitor | — | Bjørnetrø et al. (2019) |
Colon cancer | Suppressor | TNM | — | Jacob et al. (2017) |
Suppressor | Cell proliferation, metastasis and lymph node inhibitor, tumor stage | LncRNA PVT1/miR-30d-5p/RUNX2 axis | Yu et al. (2018) | |
Prostate cancer | Suppressor | Cell proliferation, and migration inhibitor | Targeting NT5E | Song et al. (2018) |
Suppressor | Cell proliferation inhibitor | AR (Androgen receptor) regulating | Kumar et al. (2016) | |
Esophageal squamous cell carcinoma | Suppressor | Cell proliferation, migration, invasion inhibitor, and EMT inhibitor | LOC440173/miR-30d-5p/HDAC9 axis | Wang et al. (2020) |
Suppressor | Cell proliferation and invasion inhibitor, EMT inhibitor | Sponged by DDX11-AS1, regulating SNAI1/ZEB2 and Wnt/β-catenin pathway | Guo et al. (2021) | |
Renal cell carcinoma | Suppressor | Cell proliferation inhibitor, and autophagy promotor | Targeting ATG5 | Liang et al. (2021) |
Pancreatic cancer | Suppressor | Metastasis | miR-30d-5p/GJA1 CTNNA1, CTNNB1, CTNND1 | Zheng et al. (2021) |
Osteosarcoma | Oncogene | Cell migration, invasion, proliferation inhibitor, apoptosis promotor, and EMT | Regulating SOCS3/JAK2/STAT3 pathway | Hu Y. et al. (2021) |
Thyroid cancer | Suppressor | Tumorigenesis | LINC00284/miR-30d-5p/ADAM12 regulating Notch signaling pathway | Hu C. et al. (2021) |
Hepatocellular carcinoma | Suppressor | Cell migration inhibitor | — | Yu et al. (2019) |
Suppressor | Autophagy | Targeting GLDC | Zhuang et al. (2019) |